INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 17 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $24,000 | -25.0% | 70,536 | 0.0% | 0.00% | – |
Q4 2021 | $32,000 | -34.7% | 70,536 | 0.0% | 0.00% | – |
Q3 2021 | $49,000 | -5.8% | 70,536 | 0.0% | 0.00% | – |
Q2 2021 | $52,000 | -25.7% | 70,536 | 0.0% | 0.00% | – |
Q1 2021 | $70,000 | +337.5% | 70,536 | +252.7% | 0.00% | – |
Q4 2020 | $16,000 | -11.1% | 19,998 | +56.8% | 0.00% | – |
Q3 2020 | $18,000 | – | 12,751 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEDBUSH SECURITIES INC | 81,491 | $116,000 | 0.01% |
NewSquare Capital LLC | 62 | $0 | 0.00% |
UBS Group AG | 6,303 | $9,000 | 0.00% |
Sugarloaf Wealth Management, LLC | 1 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 32 | $0 | 0.00% |
Jacobi Capital Management LLC | 1 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 39 | $0 | 0.00% |
FLAGSHIP HARBOR ADVISORS, LLC | 1 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 32 | $0 | 0.00% |
NORTHERN TRUST CORP | 12,751 | $18,000 | 0.00% |